{"schema_version":"secwatch.filing_event.v1","accession":"0001803737-25-000047","form_type":"8-K","ticker":"EHAB","cik":"0001803737","company_name":"Enhabit, Inc.","filed_at":"2025-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.937966+00:00","generated_at":"2026-05-25T10:58:39.899495+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Enhabit Q4 net loss $46M on $53.8M goodwill impairment; hospice revenue up 13% YoY; issues FY2025 guidance","bullets":["Net loss $46.0M (diluted EPS -$0.92) vs loss $6.4M a year ago; includes $53.8M non-cash goodwill impairment.","Adjusted EBITDA $25.1M (0.4% decline); adjusted EPS $0.04 vs $0.06.","Home health revenue $200.4M (-4.3%); hospice revenue $57.8M (+13.1%) with 8.6% ADC growth.","FY2025 guidance: revenue $1.05-1.08B, adj. EBITDA $101-107M, adj. EPS $0.41-0.51.","Reduced bank debt $10M in Q4 ($40M total in 2024); opened three hospice de novo locations."],"urls":{"canonical":"https://secwatch.observer/filing/0001803737-25-000047","json":"https://secwatch.observer/filing/0001803737-25-000047.json","markdown":"https://secwatch.observer/filing/0001803737-25-000047.md","text":"https://secwatch.observer/filing/0001803737-25-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1803737/000180373725000047/0001803737-25-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1803737/000180373725000047/ehab-20250305.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T10:58:39.899495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}